Skip to main content
SpringerLink
Log in

Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson’s disease

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Anderson, C, H Checkoway, GM Franklin, S Beresford, T Smith-Weller and PD Swanson (1999) Dietary factors in Parkinson's disease: the role of food groups and specific foods.Mov. Disord. 14, 21–27.

    Article  PubMed  CAS  Google Scholar 

  • Aoki S, Y Okada, K Nishimura, AJ Barkovich, BO Kjos, RC Brasch and D Norman (1989) Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T.Radiology 172, 381–385.

    PubMed  CAS  Google Scholar 

  • Baba M, S Nakajo, PH Tu, T Tomita, K Nakaya, VM Lee, JQ Trojanowski and T Iwatsubo (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.Am. J. Pathol. 152, 879–884.

    PubMed  CAS  Google Scholar 

  • Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Ann. Neurol. 31, 119–130.

    Article  PubMed  CAS  Google Scholar 

  • Ben-Shachar D and MB Youdim (1993) Iron, melanin and dopamine interaction: relevance to Parkinson's disease. Prog. Neuropsychopharmacol.Biol. Psychiatry 17, 139–150.

    Article  CAS  Google Scholar 

  • Brooks AI, CA Chadwick, HA Gelbard, DA Cory-Slechta and HJ Federoff (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss.Brain Res. 823, 1–10.

    Article  PubMed  CAS  Google Scholar 

  • bin/cas/tree/store/bres/cas_sub/browese/browse.cgi?year=1999&vol ume=1823&i ssue=1991–1992&aid=15178.

  • Burkitt MJ, MB Kadiiska, PM Hanna, SJ Jordan and RP Mason (1993) Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning.Mol. Pharmacol. 43, 257–263.

    PubMed  CAS  Google Scholar 

  • Bus JS and JE Gibson (1984) Paraquat: model for oxidant-initiated toxicity.Environ. Health Perspect. 55, 37–46.

    Article  PubMed  CAS  Google Scholar 

  • Castellani RJ, SL Siedlak, G Perry and MA Smith (2000) Sequestration of iron by Lewy bodies in Parkinson's disease.Acta Neuropathol. (Berl.)100, 111–114.

    Article  CAS  Google Scholar 

  • Chun HS, GE Gibson, LA DeGiorgio, H Zhang, VJ Kidd and JH Son (2001) Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism.J. Neurochem. 76, 1010–1021.

    Article  PubMed  CAS  Google Scholar 

  • Clejan L and AI Cederbaum (1989) Synergistic interactions between NADPH-cytochrome P-450 reductase, paraquat, and iron in the generation of active oxygen radicals.Biochem. Pharmacol. 38, 1779–1786.

    Article  PubMed  CAS  Google Scholar 

  • Corasaniti MT, MC Strongoli, D Rotiroti, G Bagetta and G Nistico (1998) Paraquat: a useful tool for thein vivo study of mechanisms of neuronal cell death.Pharmacol. Toxicol. 83, 1–7.

    Article  PubMed  CAS  Google Scholar 

  • D'Amato RJ, GM Alexander, RJ Schwartzman, CA Kitt, DL Price and SH Snyder (1987) Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.Nature 327, 324–326.

    Article  PubMed  Google Scholar 

  • Dexter DT, CJ Carter, FR Wells, F Javoy-Agid, Y Agid, A Lees, P Jenner and CD Marsden (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.J. Neurochem. 52, 381–389.

    Article  PubMed  CAS  Google Scholar 

  • Dexter DT, A Carayon, M Vidailhet, M Ruberg, F Agid, Y Agid, AJ Lees, FR Wells, P Jenner and CD Marsden (1990) Decreased ferritia levels in brain in Parkinson's disease.J. Neurochem. 55, 16–20.

    Article  PubMed  CAS  Google Scholar 

  • Duda JE, VM Lee and JQ Trajanowski (2000) Neuropathology of synuclein aggregates.J. Neurosci. Res. 61, 121–127.

    Article  PubMed  CAS  Google Scholar 

  • Fahn S and G Cohen (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.Ann. Neurol. 32, 804–812.

    Article  PubMed  CAS  Google Scholar 

  • Feany MB and WW Bender (2000) A Drosophila model of Parkinson's disease.Nature 404, 394–398.

    Article  PubMed  CAS  Google Scholar 

  • Fredriksson A, M Fredriksson and P Eriksson (1993) Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice.Toxicol. Appl. Pharmacol. 122, 258–264.

    Article  PubMed  CAS  Google Scholar 

  • Gerlach M, H Desser, MB Youdim and P Riederer (1996) New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.J. Neural Transm. Suppl.48, 7–21.

    CAS  Google Scholar 

  • Giasson BL, R Jakes, M Goedert, JE Duda, S Leight, JQ Trojanowski and VM Lee (2000) A panel of epitope-specific antibodies detects protein domains distributed throughout human α-synuclein in Lewy bodies of Parkinson's disease.J. Neurosci. Res. 59, 528–533.

    Article  PubMed  CAS  Google Scholar 

  • Gorell JM, BA Rybicki, C Cole Johnson and EL Peterson (1999) Occupational metal exposures and the risk of Parkinson's disease.Neuroepidemiology 18, 303–308.

    Article  PubMed  CAS  Google Scholar 

  • Gorell IM, CC Johnson, BA Rybicki, EL Peterson and RJ Richardson (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living.Neurology 50, 1346–1350.

    PubMed  CAS  Google Scholar 

  • Gutteridge JM (1992) Iron and oxygen radicals in brain.Ann. Neurol. 32 (Suppl.), S16-S21.

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto M, A Takeda, LJ Hsu, T Takenouchi and E Masliah (1999) Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease.J. Biol. Chem. 274, 28849–28852.

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto M, LJ Hsu, E Rockestein, T Takenouchi, M Mallory and E Masliah (2002) α-Synuclein protects against oxidative stress via inactivation of the c-junN-terminal kinase stress signaling pathway in neuronal cells.J. Biol. Chem. 14, 14.

    Google Scholar 

  • Hertzman C, M Wiens, D Bowering, B Snow and D Calne (1990) Parkinson's disease: a case-control study of occupational and environmental risk factors.Am. J. Ind. Med. 17 349–355.

    Article  PubMed  CAS  Google Scholar 

  • Hirsch EC (1992) Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?Ann. Neurol. 32, S88-S93.

    Article  PubMed  CAS  Google Scholar 

  • Hirsch EC, AM Graybiel and Y Agid (1989) Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.Acta Neurol. Scand. Suppl.126, 19–22.

    Article  CAS  Google Scholar 

  • Hsu LJ, Y Sagara, A Arroyo, E Rockenstein, A Sisk, M Mallory, J Wong, T Takenouchi, M Hashimoto and E Masliah (2000) α-Synuclein promotes mitochondrial deficit and oxidative stress.Am. J. Pathol. 157, 401–410.

    PubMed  CAS  Google Scholar 

  • Hubble JP, T Cao, RE Hassanein, JS Neuberger and WC Koller (1993) Risk factors for Parkinson's disease.Neurology 43, 1693–1697.

    PubMed  CAS  Google Scholar 

  • Imaizumi Y (1995) Geographical variations in mortality from Parkinson's disease in Japan, 1977–1985.Acta Neurol. Scand. 91, 311–316.

    Article  PubMed  CAS  Google Scholar 

  • Jellinger KA, E Kienzl, G Rumpelmaier, W, Paulus, P Riederer, H Stachelberger, MB Youdim and D Ben-Shachar (1993) Iron and ferritin in substantia nigra in Parkinson's disease.Adv. Neurol. 60, 267–272.

    PubMed  CAS  Google Scholar 

  • Jenner P (1993) Altered mitochondrial function, iron metabolism and glutathone levels in Parkinson's disease.Acta Neurol. Scand. Suppl.146, 6–13.

    CAS  Google Scholar 

  • Jenner P and CW Olanow (1998) Understanding cell death in Parkinson's disease.Ann. Neurol. 44, S72-S84.

    PubMed  CAS  Google Scholar 

  • Jha N, MJ Kumar, R Boonplueang and JK Andersen (2002) Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease?J. Neurochem. 80, 555–561.

    Article  PubMed  CAS  Google Scholar 

  • Jimenez-Jimenez FJ, D Mateo and S Gimenez-Roldan (1992) Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area.Mov. Disord. 7, 149–152.

    Article  PubMed  CAS  Google Scholar 

  • Junn E and MM Mouradian (2002) Human α-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.Neurosci. Lett. 320, 146–150.

    Article  PubMed  CAS  Google Scholar 

  • Kadiiska MB, PM Hanna and RP Mason (1993)In vivo ESR spin trapping evidence for hydroxyl radical-mediated toxicity of paraquat and copper in rats.Toxicol. Appl. Pharmacol. 123, 187–192.

    Article  PubMed  CAS  Google Scholar 

  • Kaur D, F Yantiri, S Rajagopalan, J Kumar, JQ Mo, R Boonplueang, D Viswanath, R Jacobs, L Yang, MF Beal, D DiMonte, I Volitaskis, L Ellerby, RA Cherny, AI Bush and JK Andersen (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicityin vivo. A novel therapy for Parkinson's disease.Neuron 37, 899–909.

    Article  PubMed  CAS  Google Scholar 

  • Koller WC (1986) Paraquat and Parkinson's disease.Neurology 36, 1147.

    PubMed  CAS  Google Scholar 

  • Kruger R, W Kuhn, T Muller, D Woitalla, M Graeber, S Kosel, H Przuntek, JT Epplen, L Schols and O Riess (1998) Ala 30Pro mutation in the gene encoding α-synuclein in Parkinson's disease.Nature Genet. 18, 106–108.

    Article  PubMed  CAS  Google Scholar 

  • Lan J and DH Jiang (1997a) Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice.J. Neural Transm. 104, 469–481.

    Article  PubMed  CAS  Google Scholar 

  • Lan J and DH Jiang (1997b) Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease.J. Neural Transm. 104, 649–660.

    Article  PubMed  CAS  Google Scholar 

  • Langston JW, P Ballard, JW Tetrud and I Irwin (1983) Chronic Parkinsonism in humans due to a product of meperidine analog synthesis.Science 219, 979–980.

    Article  PubMed  CAS  Google Scholar 

  • Lanska DJ (1997) The geographic distribution of Parkinson's disease mortality in the United States.J. Neurol. Sci. 150, 63–70.

    Article  PubMed  CAS  Google Scholar 

  • Lee M, D Hyun, B Halliwell and P Jenner (2001) Effect of the overexpression of wild-type or mutant α-synuclein or cell susceptibility to insult.J. Neurochem. 76, 998–1009.

    Article  PubMed  CAS  Google Scholar 

  • Liou HH, RC Chen, YF Tsai, WP Chen, YC Chang and MC Tsai (1996) Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies.Toxicol. Appl. Pharmacol. 137, 34–41.

    Article  PubMed  CAS  Google Scholar 

  • Liou HH, MC Tsai, CJ Chen, JS Jeng, YC Chang, SY Chen and RC Chen (1997) Environmental risk factors and Parkinson's disease: a case-control study in Taiwan.Neurology 48, 1583–1588.

    PubMed  CAS  Google Scholar 

  • Liou HH, RC Chen, TH Chen, YF Tsai and MC Tsai (2001) Attenuation of paraquat-induced dopaminergic toxicity on the substantia migra by (−)-deprenylin vivo.Toxicol. Appl. Pharmacol. 172, 37–43.

    Article  PubMed  CAS  Google Scholar 

  • Logroscino G, K Marder, J Graziano, G Freyer, V Slavkovich, N Lojacono, L Cote and R Mayeux (1998) Dietary iron, animal fats, and risk of Parkinson's disease.Mov. Disord. 13, 13–16.

    Article  PubMed  Google Scholar 

  • Manning-Bog AB, AL McCormack, J Li, VN Uversky, AL Fink and D Di Monte (2002) The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice: paraquat and α-synuclein.J. Biol. Chem. 277, 1641–1644.

    Article  PubMed  CAS  Google Scholar 

  • Masliah E, E Rockenstein, I Veinbergs, M Mallory, M Hashimoto, A Takeda, Y Sagara, A Sisk and L Mucke (2000) Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders.Science 287, 1265–1269.

    Article  PubMed  CAS  Google Scholar 

  • McCormack AL and D Di Monte (2003) Effects of l-dopa and other amino acids against paraquat-induced nigrostriatal degeneration.J. Neurochem. 85, 82–86.

    Article  PubMed  CAS  Google Scholar 

  • McCormack AL, M Thiruchelvam, AB Manning-Bog, C Thiffault, JW Langston, DA Cory-Slechta and DA DiMonte (2002) Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.Neurobiol. Dis. 10(2), 119–127.

    Article  PubMed  CAS  Google Scholar 

  • Munch G, HJ Luth, A Wong, T Arendt, E Hirsch, R Ravid and P Riederer (2000) Crosslinking of α-synuclein by advanced glycation endproducts—an early pathophysiological step in Lewy body formation?J. Chem. Neuroanat. 20, 253–257.

    Article  PubMed  CAS  Google Scholar 

  • Ostrerova-Golts N, L Petrucelli, J Hardy, JM Lee, M Farer and B Wolozin (2000) The A53T α-synuclein mutation increases irondependent aggregation and toxicity.J. Neurosci. 20, 6048–6054.

    PubMed  CAS  Google Scholar 

  • Paik SR, HJ Shin, JH Lee, CS Chang and J Kim (1999) Copper(II)-induced self-oligomerization of α-synuclein.Biochem. J. 340, 821–828.

    Article  PubMed  CAS  Google Scholar 

  • Perry TL and VW Yong (1986) Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.Neurosci. Lett. 67, 269–274.

    Article  PubMed  CAS  Google Scholar 

  • Perry TL, DV Godin and S Hansen (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency?Neurosci. Lett. 33, 305–310.

    Article  PubMed  CAS  Google Scholar 

  • Perry TL, VW Yong, RA Wall and K Jones (1986) Paraquat and two endogenous analogues of the neurotoxic substanceN-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to not damage dopaminergic nigrostriatal neurons in the mouse.Neurosci. Lett. 69, 285–289.

    Article  PubMed  CAS  Google Scholar 

  • Poirier J, J Donaldson and A Barbeau (1985) The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals.Biochem. Biophys. Res. Commun. 128, 25–33.

    Article  PubMed  CAS  Google Scholar 

  • Polymeropoulos MH, C Lavedan, E Leroy, SE Ide, A Dehejia, A Dutra B Pike, H Root, J Rubenstein, R Boyer, ES Stenroos, S Chandrasekharappa, A Athanassiadou, T Papapetropoulos, WG Johnson, AM Lazzarini, RC Duvoisin, G Di Iorio, LI Golbe and RL Nussbaum (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease.Science 276, 2045–2047.

    Article  PubMed  CAS  Google Scholar 

  • Przedborski S, V Jackson-Lewis, AB Naini, M Jakowec, G Petzinger, R Miller and M Akram (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.J. Neurochem. 76, 1265–1274.

    Article  PubMed  CAS  Google Scholar 

  • Riederer P, E Sofic, WD Rausch, B Schmidt, GP Reynolds, K Jellinger and MB Youdim (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.J. Neurochem. 52, 515–520.

    Article  PubMed  CAS  Google Scholar 

  • Schneider JS and FJ Denaro (1988) Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.J. Neuropathol. Exp. Neurol. 47, 452–458.

    Article  PubMed  CAS  Google Scholar 

  • Semchuk KM, EJ Love and RG Lee (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals.Neurology 42, 1328–1335.

    PubMed  CAS  Google Scholar 

  • Shimada H, K Hirai, E Simamura and J Pan (1998) Mitochondrial NADH-quinone oxidoreductase of the outer membrane is responsible for paraquat cytotoxicity in rat livers.Arch. Biochem. Biophys. 351, 75–81.

    Article  PubMed  CAS  Google Scholar 

  • Shimizu K, K Ohtaki, K Matsubara, K Aoyama, T Uezono, O Saito, M Suno, K Ogawa, N Hayase, K Kimura and H Shiono (2001) Carrier mediated processes in blood-brain barrier penetration and neural uptake of paraquat.Brain Res. 906, 135–142

    Article  PubMed  CAS  Google Scholar 

  • Sofic E, W Paulus, K Jellinger, P Riederer and MB Youdim (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.J. Neurochem. 56, 978–982.

    Article  PubMed  CAS  Google Scholar 

  • Spillantini MG, ML Schmidt, VM Lee, JQ Trojanowski, R Jakes and M Goedert (1997) α-Synuclein in Lewy bodies.Nature 388, 839–840.

    Article  PubMed  CAS  Google Scholar 

  • Spillantini MG, RA Crowther, R Jakes, M Hasegawa and M Goedert (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies.Proc. Natl. Acad. Sci. USA 95, 6469–6473.

    Article  PubMed  CAS  Google Scholar 

  • Stephenson J (2000) Exposure to home pesticides linked to Parkinson disease.JAMA 283, 3055–3056.

    Article  PubMed  CAS  Google Scholar 

  • Tanner CM, R Ottman, SM Goldman, J Ellenberg, P Chan, R Mayeux and JW Langston (1999) Parkinson disease in twins: an etiologic study.JAMA 281, 341–346.

    Article  PubMed  CAS  Google Scholar 

  • Taylor EM and EH Morgan (1990) Developmental changes in transferrin and iron uptake by the brain in the rat.Brain Res. Dev. Brain Res. 55, 35–42.

    Article  PubMed  CAS  Google Scholar 

  • Taylor EM, A Crowe and EH Morgan (1991) Transferrin and iron uptake by the brain: effects of altered iron status.J. Neurochem. 57, 1584–1592.

    Article  PubMed  CAS  Google Scholar 

  • Thiruchelvam M, BJ Brockel, EK Richfield, RB Baggs and DA Cory-Slechta (2000) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?Brain Res. 873, 225–234.

    Article  PubMed  CAS  Google Scholar 

  • Trojanowski JQ and VM Lee (1998) Aggregation of neurofilament and α-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.Arch. Neurol. 55, 151–152.

    Article  PubMed  CAS  Google Scholar 

  • Trojanowski JQ, M Goedert, T Iwatsubo and VM Lee (1998) Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.Cell Death Differ. 5, 832–837.

    Article  PubMed  CAS  Google Scholar 

  • Uversky VN, J Li and AL Fink (2001a) Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.J. Biol. Chem. 276, 44284–44296.

    Article  PubMed  CAS  Google Scholar 

  • Uversky VN, J Li and AL Fink (2001b) Pesticides directly accelerate the rate of α-synuclein fibril formation: a possible factor in Parkinson's disease.FEBS Lett. 500, 105–108.

    Article  PubMed  CAS  Google Scholar 

  • Widdowson PS, MJ Farnworth, MG Simpson and EA Lock (1996a) Influence of age on the passage of paraquat through the blood-brain barrier in rats: a distribution and pathological examination.Hum. Exp. Toxicol. 15, 231–236.

    Article  PubMed  CAS  Google Scholar 

  • Widdowson PS, MJ Farnworth, R Upton and MG Simpson (1996b) No changes in behaviour, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats.Hum. Exp. Toxicol. 15, 583–591.

    Article  PubMed  CAS  Google Scholar 

  • Yang L, RT Matthews, JB Schulz, T Klockgether, AW Liac, JC Martinou, JB Penney Jr, BT Hyman and MF Beal (1998) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.J. Neurosci. 18, 8145–8152.

    PubMed  CAS  Google Scholar 

  • Yang W and AY Sun (1998) Paraquat-induced free radical reaction in mouse brain microsomes.Neurochem. Res. 23, 47–53.

    Article  PubMed  CAS  Google Scholar 

  • Youdim MB, D Ben-Schachar and P Riederer (1993) The possible role of iron in the etiopathology of Parkinson's disease [published erratum appears inMov. Disord. 1993 Apr;8(2):255].Mov. Disord. 8, 1–12.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Buck Institute for Age Research, 8001 Redwood Blvd., 94945, Novato, CA, USA

    Julie K. Andersen

Authors
  1. Julie K. Andersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie K. Andersen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersen, J.K. Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson’s disease. neurotox res 5, 307–313 (2003). https://doi.org/10.1007/BF03033150

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033150

Keywords

Search

Navigation